Home/Auransa/Pek Lum

PL

Pek Lum

Co-Founder and CEO

Therapeutic Areas

Auransa Pipeline

Drug	Indication	Phase
AU-409	Liver Cancer (Hepatocellular Carcinoma)	Phase 1
AU-018	Heart-Safe Chemotherapy (Anthracycline-induced cardiotoxicity)	IND enabling

Leadership Team at Auransa

Viwat Visuthikraisee

Co-Founder and COO

Chief Scientific Officer

Professor, Integrative Biology and Physiology, Molecular and Medical Pharmacology, UCLA

View full Auransa profile